Assembly Biosciences, Inc.ASMBNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank88
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-14.25%
↑ 97% vs avg
Percentile
P88
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-493.82%
Historical baseline
PeriodValueYoY Change
TTM-14.25%+91.0%
2024-158.80%+82.3%
2023-896.22%-
20220.00%+100.0%
2021-1448.42%-1861.9%
2020-73.83%+88.6%
2019-649.78%-3.7%
2018-626.42%-8.6%
2017-576.67%-